insights_auto
Hvorfor har CSBR gått ned? 4,21%?
Gå mer i dybdenchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,40 USD
arrow_downward
−4,21%(−0,19) 1 D
19. nov., 16:00:00 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,47 USD
Høy
4,47 USD
Lav
4,40 USD
Markedsverdi
61,24 mill.
Snittvolum
6,90k
Volum
4,87k
52 u høy
8,31 USD
52 u lav
4,40 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,47 USD
Høy
4,47 USD
Lav
4,40 USD
Markedsverdi
61,24 mill.
Snittvolum
6,90k
Volum
4,87k
52 u høy
8,31 USD
52 u lav
4,40 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
The Motley Fool
·
for 1 time siden
The S&P 500 Just Fell 4 Straight Weeks From a Record High. Here’s Why I’m Buying the Dip.
FXStreet
·
for 4 timer siden
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
for 4 timer siden
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
for 1 time siden
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com